Doctors' Offices Preferred COVID Vaccine Sites for Unvaccinated Doctors' Offices Preferred COVID Vaccine Sites for Unvaccinated
A new survey finds that vaccine-hesitant patients, by a wide margin, would like to get shots from their personal physicians; racial attitudes toward vaccination vary.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 18, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

FDA Approves Astepro Allergy (azelastine) Nasal Spray for Over-the-Counter Use
WHIPPANY, N.J.--(BUSINESS WIRE) June 17, 2021-- Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Astepro Allergy (Azelastine HCI .15%) as an over-the-counter (OTC) product for the temporary relief of nasal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 17, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves a Nasal Antihistamine for Nonprescription Use
FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 17, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products
Specific batches of products supplied by Bristol Laboratories Limited, Brown& Burk UK Limited and Teva UK Limited are being recalled due to presence of a mutagenic impurity. Further information (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 17, 2021 Category: Drugs & Pharmacology Source Type: news

Pharmacy can help reduce drug harms and deaths
We have published a policy document on pharmacy’s role in reducing drug harms and preventing drug deaths in Scotland. The report highlights areas where pharmacy can contribute effectively to the (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 17, 2021 Category: Drugs & Pharmacology Source Type: news

LIVFRESH Becomes the World ’s First European Union CE Mark Certified Toothpaste for Prevention & Treatment of Periodontitis & Gingivitis as an Adjunct to Professional Care
~ As Mounting Evidence Connects Gum Disease to Covid Complications, Silicon Valley Based LIVFRESH Dental Gel is approved in the European Union as the First Over the Counter Toothpaste for Consumers Suffering from Periodontitis or Gingivitis. These Oral Diseases Affect up to 90% of All Adults.Los Gatos, CA —June 2, 2021—As the world continues to fight COVID, and since serious gum disease (periodontitis) has been implicated as a complicating factor, good oral health is more important than ever.   Livionex Inc., the company behind LivFresh Dental Gel, today, announced its therapeutic non-abrasive and det...
Source: Dental Technology Blog - June 17, 2021 Category: Dentistry Source Type: news

Rebuilding Trust in Healthcare Key to Recharging Vaccine Uptake Rebuilding Trust in Healthcare Key to Recharging Vaccine Uptake
Hesitancy can ’t be the only excuse given for why COVID-19 vaccine uptake has plateaued, says a thought leader on the subject. Health systems have some hard questions to ask of themselves.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 16, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Giving Flu and COVID Shots at Same Time Appears Safe, Effective: Study Giving Flu and COVID Shots at Same Time Appears Safe, Effective: Study
New research suggests the Novavax COVID-19 vaccine can be given at the same time as the flu vaccine.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 16, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

FDA approves avapritinib for advanced systemic mastocytosis
Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

How Patent Extensions Keep Some Drug Costs High How Patent Extensions Keep Some Drug Costs High
The Biden administration has a chance to help curb drug costs by naming a new patent office director, some experts say.Undark (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 16, 2021 Category: Drugs & Pharmacology Tags: HIV/AIDS News Source Type: news

Secukinumab Provides Clinical Benefit for JIA Subtypes Secukinumab Provides Clinical Benefit for JIA Subtypes
Phase 3 trial shows secukinumab is effective for enthesitis-related arthritis and juvenile psoriatic arthritis in children.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 16, 2021 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Co-codamol 30/500 Effervescent Tablets
Zentiva Pharma UK Limited is recalling a batch of Co-codamol 30/500 Effervescent Tablets as a precautionary measure due to an issue with the homogeneity of the batch. This issue means that there is th (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 16, 2021 Category: Drugs & Pharmacology Source Type: news

Hundreds sign Inclusion and Wellbeing Pledge in first week
The RPS Inclusion and Wellbeing Pledge is a serious commitment to be inclusive, celebrate diversity, create a culture of belonging, and support pharmacy teams’ health and wellbeing. Since it wa (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 16, 2021 Category: Drugs & Pharmacology Source Type: news

Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine for Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 16, 2021 Category: Drugs & Pharmacology Source Type: news

Tembexa (Brincidofovir Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 16, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia
DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres (ephedrine hydrochloride injection) for the treatment of clinically... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 15, 2021 Category: Drugs & Pharmacology Source Type: news

Public Notification: Fruta Bio contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Fruta Bio, a product promoted and sold for weight loss on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Fruta Planta contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Fruta Planta, a product promoted and sold for weight loss on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Burn 7 contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Burn 7, a product promoted and sold for weight loss on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Imperla Elita Vitaccino contains hidden drug ingredients
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Imperla Elita Vitaccino, a product promoted and sold for weight loss on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Lishou Slimming Coffee contains hidden drug ingredients
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Lishou Slimming Coffee, a product promoted and sold for weight loss on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Li Da Daidaihua Plus contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Li Da Daidaihua Plus, a product promoted and sold for weight loss on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Black Stallion 9000 contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Black Stallion 9000, a product promoted and sold for sexual enhancement on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Blue Panther Extreme 75k contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Blue Panther Extreme 75k, a product promoted and sold for sexual enhancement on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Gold Lion contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Gold Lion, a product promoted and sold for sexual enhancement on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Mero Macho contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Mero Macho, a product promoted and sold for sexual enhancement on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Public Notification: Poseidon Platinum 3500 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Poseidon Platinum 3500, a product promoted and sold for sexual enhancement on various websites, including eBay.com, and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Safety Risks Associated with Certain Bulk Drug Substances Nominated for Use in Compounding
Category 2 of the Bulk Substances Nominated Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

NHS England sends letter to women and girls taking sodium valproate
NHS England has sent a letter to women and girls aged 12-55 years of age who are currently prescribed sodium valproate. Itcontains important reminders of safety considerations, including around contra (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 15, 2021 Category: Drugs & Pharmacology Source Type: news

Confirmation of flu vaccination training for 2021-2022
PSNC has confirmed thatthe normal training requirements for pharmacists providing the flu vaccination service are being reinstated for the 2021/22 season. PSNC has statedthat pharmacists will be expe (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 15, 2021 Category: Drugs & Pharmacology Source Type: news

Increlex (mecasermin [rDNA origin])
Title: Increlex (mecasermin [rDNA origin])Category: MedicationsCreated: 6/15/2021 12:00:00 AMLast Editorial Review: 6/15/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 15, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Recalls More Metformin Extended-Release Tablets FDA Recalls More Metformin Extended-Release Tablets
Two lots of metformin HCl extended-release tablets have been recalled by Viona Pharmaceuticals because unacceptable levels of nitrosodimethylamine, a likely carcinogen, were found in the 750-mg tablets.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 15, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

Older Therapies Aren ’t Necessarily Better for Thyroid Hormone Replacement
Millions of people have thyroid glands that don ’t make enough thyroid hormone to meet their body’s needs. Hypothyroidism (underactive thyroid) is the most common reason some people need thyroid hormone replacement. Today, there are modern, synthetic (laboratory-made) medications approved by the FDA. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 14, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Internet Pharmacy Warning Letters
Rogue online pharmacies offer potentially dangerous prescription drugs to U.S. consumers. FDA has issued warning letters informing the website operators that they are engaged in illegal activity in violation of the U.S. Federal Food, Drug, and Cosmetic Act (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 14, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Other OMUFA Fee-Related Questions
, specific to OMUFA arrears list. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 14, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

As COVID Restrictions Ease, RSV and Other Viruses Re-Eemerge As COVID Restrictions Ease, RSV and Other Viruses Re-Eemerge
The CDC urges more testing for RSV among patients presenting with acute respiratory illness who test negative for SARS-CoV-2. RSV is just one of the viruses reemerging as COVID restrictions lift.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 12, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Viona Pharmaceuticals Inc., is voluntarily recalling 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves isatuximab-irfc for multiple myeloma
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves ibrutinib plus rituximab for chronic lymphocytic leukemia
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves new dosing regimen for pembrolizumab
Hematology/Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves niraparib for first-line maintenance of advanced ovarian cancer
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma
Hematology / Oncology News (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA grants accelerated approval to capmatinib for metastatic non-small cell lung cancer
FDA granted accelerated approval to capmatinib (TABRECTATM, Novartis) for adult patients with metastatic non-small cell lung cancer whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves selpercatinib for lung and thyroid cancers with RET gene mutations or fusions
Hematology/Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves olaparib plus bevacizumab as maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancers
Hematology / Oncology Drug Approvals (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumor expression ≥1%)
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves ripretinib for advanced gastrointestinal stromal tumor
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA approves olaparib for HRR gene-mutated metastatic castration-resistant prostate cancer
Oncology / Hematology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news